CROMER GROUP PRACTICE
MILL ROAD, CROMER
Stroke 12
The % of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record that an anti-platelet agent (aspirin, clopidogrel, dipyridamole or a combination), or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| STROKE 9 | 2005 | 102 | 110 | 92.7% | |
| STROKE 9 | 2006 | 127 | 137 | 92.7% | |
| Stroke 12 | 2007 | 178 | 194 | 91.8% | |
| Stroke 12 | 2008 | 207 | 219 | 94.5% | |
| Stroke 12 | 2009 | 217 | 237 | 91.6% | |
| Stroke 12 | 2010 | 222 | 239 | 92.9% | |
| STROKE 12 | 2011 | 236 | 249 | 94.8% | |
| STROKE 12 | 2012 | 243 | 264 | 92.0% | |
| STROKE 12 | 2013 | 236 | 254 | 92.9% | |
| STIA007 | 2014 | 256 | 264 | 97.0% | |
| STIA007 | 2015 | 270 | 280 | 96.4% | |
| STIA007 | 2016 | 279 | 286 | 97.6% | |
| STIA007 | 2017 | 276 | 281 | 98.2% | |
| STIA007 | 2018 | 289 | 293 | 98.6% | |
| STIA007 | 2019 | 291 | 303 | 96.0% | |
| STIA007 | 2020 | 286 | 286 | 100.0% | |
| STIA007 | 2021 | 288 | 288 | 100.0% | |
| STIA007 | 2022 | 294 | 297 | 99.0% | |
| STIA007 | 2023 | 293 | 344 | 85.2% |
